Picture of Arecor Therapeutics logo

AREC — Arecor Therapeutics Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual cashflow statement for Arecor Therapeutics, fiscal year end - December 31st, millions except per share.

2017
May 31st
2018
May 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M7 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:
fx
Preliminary
FinalFinalFinalFinal
Net Income/Starting Line
Depreciation
Amortisation
Non-Cash Items
Other Non-Cash Items
Changes in Working Capital
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities
Capital Expenditures
Purchase of Fixed Assets
Other Investing Cash Flow Items
Other Investing Cash Flow
Cash from Investing Activities
Financing Cash Flow Items
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash

Or unlock with your email

Or unlock with your email